Chemotherapy Drugs Market Report Forecast (2013-2023)
What does the study recommend to the industry players in
the Chemotherapy Drugs market?
On the basis of type of chemotherapy drug, plant alkaloids
and antitumor antibiotics have been witnessing growth at a noteworthy rate over
the past few years backed by effective use of these medications for the
treatment of several varieties of cancers such as breast, ovarian, lung,
bladder, prostate, melanoma, esophageal, as well as other types of solid
tumors, etc. Amongst the regions, North America accounts for the largest
regional share in the global chemotherapy drugs market in 2018.
However, in the forecast period, the Asia Pacific region is
anticipated to advance at the highest pace. Key factors driving the robust
growth rate of Asia Pacific region include boosting production of
pharmaceuticals, growing incidence of cancer along with government’s focus on
medical infrastructural developments.
What are the major Chemotherapy Drugs segments covered in
the Azoth Analytics report?
The major Chemotherapy Drugs
segments covered in the report include Antimetabolites, Plant Alkaloids,
Alkylating Agents, Antitumor Antibiotics, Others
What are the regions and countries covered in the study
on Chemotherapy Drugs market?
The regional markets covered in the report include North
America, Europe, APAC and Rest of the World.
The countries analyzed in the report include U.S, Canada,
United Kingdom, Germany, China and India
Name the companies profiled in the report?
The companies profiled in the report include Pfizer, Eli
Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck &
Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical
Industries Limited.
What are the key factors driving the market of Chemotherapy
Drugs?
·
Rising Incidence of Cancer.
·
Growing per capita expenditure on healthcare.
·
Rapid medical infrastructure developments.
Source Url:
Comments
Post a Comment